Daily Visitors
Last scanned
Domain Age
Global Rank
Updated:
CYRAMZA® (ramucirumab) | VEGFR2 Inhibitor
CYRAMZA® is approved for the treatment of patients with advanced or metastatic stomach or gastroesophageal (GE) junction cancer, metastatic NSCLC, metastatic CRC, and AFP-High liver cancer (HCC).
This website is hosted with Amazon Technologies Inc., which reserves the following IP addresses for cyramza.com: 18.205.36.100, 52.204.242.176, 54.157.58.70, 54.162.128.250. Moreover, DNS used with this website include pdns108.ultradns.biz, pdns108.ultradns.com, pdns108.ultradns.net, pdns108.ultradns.org. Subnet identifier ranges from 18.32.0.0 to 18.255.255.255. Classless Inter-Domain Routing (CIDR) is 18.64.0.0/10, 18.32.0.0/11, 18.128.0.0/9. ARIN net type is Direct Allocation.
Daily Visitors
Last scanned
Domain Age
Global Rank
pdns108.ultradns.biz
pdns108.ultradns.com
pdns108.ultradns.net
pdns108.ultradns.org
{{value}}
2011-10-05
2024-10-05
GoDaddy Corporate Domains, LLC
{{value}}
The registrar of cyramza.com is GoDaddy Corporate Domains, LLC and the name expires on 2024-10-05. According to open source data, you can reach the owner at admin_global_domain@lilly.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
N/A
N/A
N/A
N/A
N/A
6.3K
25.6K
N/A
N/A